|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2010-12-27
|
|
pubmed:abstractText |
Vascular endothelial growth factor (VEGF) and pathologic angiogenesis have been demonstrated to play a pathogenic role in the development and progression of inflammatory bowel disease. Thus, we hypothesized that the potent anti-angiogenic factor endostatin might play a beneficial role in experimental ulcerative colitis (UC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1879-0631
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Published by Elsevier Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
74-81
|
|
pubmed:meshHeading |
pubmed-meshheading:21047522-Animals,
pubmed-meshheading:21047522-Blotting, Western,
pubmed-meshheading:21047522-Colitis, Ulcerative,
pubmed-meshheading:21047522-Colon,
pubmed-meshheading:21047522-Dextran Sulfate,
pubmed-meshheading:21047522-Disease Models, Animal,
pubmed-meshheading:21047522-Endostatins,
pubmed-meshheading:21047522-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21047522-Female,
pubmed-meshheading:21047522-Iodoacetamide,
pubmed-meshheading:21047522-Matrix Metalloproteinase 9,
pubmed-meshheading:21047522-Mice,
pubmed-meshheading:21047522-Mice, Knockout,
pubmed-meshheading:21047522-Platelet-Derived Growth Factor,
pubmed-meshheading:21047522-Rats,
pubmed-meshheading:21047522-Up-Regulation,
pubmed-meshheading:21047522-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Role of anti-angiogenic factor endostatin in the pathogenesis of experimental ulcerative colitis.
|
|
pubmed:affiliation |
Diagnostic & Molecular Medicine, Health Care Group, VA Medical Center, Long Beach, CA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
